Cargando…
Injectable Antihyperglycemics: A Systematic Review and Critical Analysis of the Literature on Adherence, Persistence, and Health Outcomes
INTRODUCTION: Improving real-world medication adherence to injectable antihyperglycemics in type 2 diabetes mellitus (T2DM) is a clinical challenge. Quantification of the level of adherence required to achieve a minimal clinically important difference (MCID) in glycemic control would assist in meeti...
Autores principales: | Hamersky, Carol M., Fridman, Moshe, Gamble, Cory L., Iyer, Neeraj N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531561/ https://www.ncbi.nlm.nih.gov/pubmed/31054132 http://dx.doi.org/10.1007/s13300-019-0617-3 |
Ejemplares similares
-
Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study
por: Polonsky, William, et al.
Publicado: (2021) -
Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis
por: Fridman, Moshe, et al.
Publicado: (2020) -
Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes
por: Tunceli, Kaan, et al.
Publicado: (2015) -
One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study
por: Huber, Carola A., et al.
Publicado: (2016) -
Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review
por: Black, Cody D., et al.
Publicado: (2016)